CoChat

Treatment of Uveitis by In Situ Administration of Ex Vivo–Activated Polyclonal Regulatory T Cells

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

CD4+CD25+Foxp3+ regulatory T (Treg) cell therapy is a promising approach for the treatment of autoimmune diseases. To be effective, Treg cells should be in an activated state in the target tissue. This can be achieved by systemic administration of Ag-specific Treg cells, which are difficult to produce in conditions that can be translated to the clinic. In this paper, we propose an alternative approach consisting of in situ injection of preactivated polyclonal Treg cells that would exert bystander suppression in the target tissue. We show that polyclonal Treg cells suppressed uveitis in mice as efficiently as Ag-specific Treg cells but only when preactivated and administered in the vitreous. Uveitis control was correlated with an increase of IL-10 and a decrease of reactive oxygen species produced by immune cell infiltrates in the eye. Thus, our results reveal a new mechanism of Treg cell–mediated suppression and a new Treg cell therapy approach.

Overview

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1501723

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 60 references

Cited by

See all 37

Metadata

Authors
Grégoire, S., Terrada, C., Martin, G. H., Fourcade, G., Baeyens, A., Marodon, G., Fisson, S., Billiard, F., Lucas, B., Tadayoni, R., Béhar-Cohen, F., Levacher, B., Galy, A., LeHoang, P., Klatzmann, D., Bodaghi, B., & Salomon, B. L.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Sorbonne Paris Cité (FR)
  • Université Paris 5, Centre de Recherche des Cordeliers , F-75006 Paris ,
  • Inserm (FR)
  • Sorbonne Universités, Université Pierre et Marie Curie Univ Paris 06, INSERM, Centre National de la Recherche Scientifique, Centre d’Immunologie et des Maladies Infectieuses (Cimi-Paris) , Laboratoire I3, F-75013 Paris ,
Corresponding author
  • Fourcade, Gwladys
  • Baeyens, Audrey
  • Marodon, Gilles
  • Fisson, Sylvain
  • Billiard, Fabienne
  • LeHoang, Phuc
  • Klatzmann, David
  • Bodaghi, Bahram
Venue
The Journal of Immunology
Published
2016-03-01
Volume
196
Issue
5
Pages
2109-2118
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2252727669
Cited by
33
References
60
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 1
FWCI
2.62
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
Keywords
uveitis, regulatory T cells, Treg therapy, in situ injection, bystander suppression, vitreous humor, IL-10, reactive oxygen species, immune cell infiltration, autoimmune disease, Foxp3
MeSH terms
Animals, Disease Models, Animal, Female, Flow Cytometry, Immunotherapy, Lymphocyte Activation, Mice, Inbred BALB C, Mice, Transgenic, Uveitis, T-Lymphocytes, Regulatory, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of Uveitis by In Situ Administration of Ex Vivo–Activated Polyclonal Regulatory T Cells. https://app.cochat.ai/papers/10.4049/jimmunol.1501723
The paper
Grégoire, S., Terrada, C., Martin, G. H., Fourcade, G., Baeyens, A., Marodon, G., Fisson, S., Billiard, F., Lucas, B., Tadayoni, R., Béhar-Cohen, F., Levacher, B., Galy, A., LeHoang, P., Klatzmann, D., Bodaghi, B., & Salomon, B. L. (2016). Treatment of Uveitis by In Situ Administration of Ex Vivo–Activated Polyclonal Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1501723

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.